[1] This is to reduce the risk of hypotension or vein irritation
These peptides also circulate through the bloodstream to reach target tissues
Ive worked with hundreds of people using GHK-Cu (glycyl-L-histidyl-L-lysine-copper) over the past decade, and the results are legitimate, measurable, and backed by solid mechanistic sciencebut you MUST understand what youre actually doing and why most people are using it improperly
At first glance, this seems paradoxical: glucagon is the hormone of energy mobilization, the opposite of insulin
Realworld risk from contamination, mislabeling, clueless dosing, and legal/regulatory exposure is much higher
As expected, according to a linear meta-regression model, tirzepatide might decrease AHI in patients with OSA and obesity 102